Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03218137 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2027v12
  2. Primary completion date: Jun 30, 2025 to Dec 31, 2025
    • Site contact updated
    v11
  3. Re-verified, no change to tracked fieldsv10
  4. Primary completion date: Dec 31, 2024 to Jun 30, 2025
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    v9
  5. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2024v8
Show 6 earlier versionsHide 6 earlier versions
  1. Re-verified, no change to tracked fieldsv7
  2. Primary and study completion dates: Dec 2021 to Dec 31, 2022v6
  3. Primary and study completion dates: Dec 2020 to Dec 2021v5
  4. Study description expanded, about 6 wordsv4
  5. Enrollment target: 20 to 100v3 Show 5 more changesShow less
    • Primary and study completion dates: Feb 2020 to Dec 2020
    • Primary endpoints: 1 to 2
    • Study description expanded, about 259 words
    • Site contact updated
    • Eligibility criteria expanded, about 4 words
  6. Primary completion date: Feb 2018 to Feb 2020
    • Study completion date: Feb 2019 to Feb 2020
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Unblinded, controlled, non-randomized, mechanistic study to determine whether physiological mechanisms underlying PVC are sensitive to adenosine. One hundred subjects undergoing clinically-indicated, standard-of-care cardiac electrophysiology study (EPS) procedure for PVCs will receive adenosine and/or verapamil to learn if their arrhythmias are inducible similarly to sustained ventricular tachycardia.
Trial Details
NCT Number NCT03218137
Lead Sponsor Weill Medical College of Cornell University
Conditions
(from sponsor)		 Premature Ventricular Contraction (PVC)
Related terms Disease, Ventricular Premature Complexes
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov